Evidence map›Paper›PMID 34285595›Full record

ArticleInternational medical case reports journal2021

Severe Pulmonary

Kazuki Takano, Daishi Shimada, Shota Kashiwagura, Yasuhiro Kamioka, Maya Hariu, Yuji Watanabe, Masafumi Seki

Open access · goldAbstract readCase Reports
In one paragraph

Article in International medical case reports journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Frontiers in cellular and infection microbiology · 2025
    Article
  6. Antimicrobial susceptibility analysis of isepamicin combination treatments inJournal of clinical tuberculosis and other mycobacterial diseases · 2024
    Article
  7. Article
  8. Sitafloxacin Expresses Potent Anti-Frontiers in microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Kazuki TakanoDivision of Infectious Diseases and Infection Control, Faculty of Medicine.
Daishi ShimadaDivision of Infectious Diseases and Infection Control, Faculty of Medicine.
Shota KashiwaguraDivision of Infectious Diseases and Infection Control, Faculty of Medicine.
Yasuhiro KamiokaDivision of Infectious Diseases and Infection Control, Faculty of Medicine.
Maya HariuDivision of Infectious Diseases and Infection Control, Faculty of Medicine.
Yuji WatanabeDivision of Infectious Diseases and Infection Control, Faculty of Medicine.ORCID 0000-0002-1021-3769
Masafumi SekiDivision of Infectious Diseases and Infection Control, Faculty of Medicine.ORCID 0000-0001-5414-8148
Biology of Infection · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCASE REPORT: We present five cases of severe pneumonia due to

conclusion

Indexed as

clarithromycinfluoroquinolonemacrolidesnon-tuberculosis mycobacteriumsitafloxacin

Identifiers

PMID34285595
PMCPMC8285566
OpenAlexW3179953828

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.